Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia
2007

Drug Prices and Availability in Malaysia

Sample size: 72 publication Evidence: moderate

Author Information

Author(s): Suzanne Hill

Hypothesis

How do drug prices and availability in Malaysia affect access to medicines?

Conclusion

The study found that drug prices in Malaysia are significantly higher than international reference prices, making many essential medicines unaffordable.

Supporting Evidence

  • Prices of common medicines vary enormously between countries and often within countries.
  • Many essential medicines would be unaffordable for a government worker based on a day's wages.
  • The study documented significant variation in the prices of a standard sample of medicines in Malaysia.

Takeaway

This study looked at how much medicines cost in Malaysia and found that many people can't afford them because prices are too high.

Methodology

The study used a standard methodology for pricing surveys developed by Health Action International and the World Health Organisation.

Limitations

The study's sample size may not be representative of the entire population of Malaysia, which limits the generalizability of the findings.

Participant Demographics

The study included data from 20 public hospitals, 32 private pharmacies, and 20 dispensing doctors.

Digital Object Identifier (DOI)

10.1371/journal.pmed.0040149

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication